BELOTERO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Belotero Revive
Belotero Revive by Merz Aesthetics is the skin quality and skin booster injectable of the BELOTERO range, an injectable resorbable implant developed to revitalise facial skin by rehydrating dry and very dry skin, improving elasticity and firmness and smoothing superficial fine lines. Its indication is early-onset photodamaged facial skin of the cheeks showing dehydration, lost elasticity and firmness, and superficial fine lines, and is placed in the mid- to deep dermis by authorised healthcare professionals. Each 1 mL syringe contains cross-linked sodium hyaluronate 20 mg/ml, produced by fermentation of Streptococcus equi, and glycerol 17.5 mg/ml in phosphate buffer at pH 7, and this presentation contains no lidocaine. The treatment regimen may be renewed at the earliest after 6 months, with a maximum annual dose of 12 mL.
主なメリット: Belotero Revive
- Injectable resorbable implant for early-onset photodamaged facial skin in the cheeks, characterised by dehydration, loss of elasticity and firmness, and superficial fine lines
- Cross-linked sodium hyaluronate 20 mg/ml with glycerol 17.5 mg/ml, in phosphate buffer at pH 7
- Glycerol as a second component is the formulation difference that separates Revive from the fillers in the range
- Contains no lidocaine, so the amide-anaesthetic contraindication that applies to the other grades does not apply here
- Rehydrates dry and very dry skin, improves elasticity and firmness, and smooths superficial fine lines rather than building facial volume
- Placed in the mid- to deep dermis by authorised healthcare professionals
- The treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 12 mL
- Hyaluronate produced by fermentation of Streptococcus equi rather than from an animal source
適応と専門的な使用
主な適応
- Revitalisation of early-onset photodamaged facial skin in the cheeks, characterised by dehydration, loss of elasticity and firmness, and the presence of superficial fine lines
- Rehydration of dry and very dry skin
- Improvement of skin elasticity and firmness
- Smoothening of superficial fine lines by reducing skin roughness
専門的な使用
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
施術部位
- Cheeks
- Skin hydration
- Skin elasticity and firmness
- Superficial fine lines and skin roughness
対象となる患者
Suitable for adult patients assessed as appropriate by the treating practitioner. BELOTERO Revive is contra-indicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, glycerol or BDDE; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, or into skin areas presenting active cutaneous inflammation or infection. This presentation contains no lidocaine, so the amide-anaesthetic contraindication that applies to the lidocaine-containing grades in the range does not apply here. Patient selection and suitability are determined by the practitioner at consultation.
作用の仕組み: Belotero Revive
Belotero Revive works through two components rather than one. Cross-linked sodium hyaluronate at 20 mg/ml provides the hydrating, revitalising base, and glycerol at 17.5 mg/ml is the second component, which is the formulation difference that separates Revive from the BELOTERO fillers. It acts as an injectable resorbable implant that rehydrates dry and very dry skin, improves elasticity and firmness and smooths superficial fine lines, rather than building facial volume. It is placed in the mid- to deep dermis, and the treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 12 mL. Because the target is skin quality rather than facial structure, it is directed at early-onset photodamage in the cheeks characterised by dehydration, loss of elasticity and firmness, and superficial fine lines. This presentation contains no lidocaine.
Allparaで注文する理由
Allparaは、正規品で検証済みの BELOTERO 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。
よくある質問
What does Belotero Revive do?
Belotero Revive is an injectable resorbable implant that revitalises early-onset photodamaged facial skin in the cheeks through rehydration of dry and very dry skin, improvement of elasticity and firmness, and smoothening of superficial fine lines. It works on skin quality rather than correcting folds or restoring volume, and is applied by an authorised healthcare professional.
How does Belotero Revive differ from a BELOTERO dermal filler?
Belotero Revive contains cross-linked sodium hyaluronate 20 mg/ml together with glycerol 17.5 mg/ml, and contains no lidocaine. The glycerol is the formulation difference that separates it from the fillers in the range, which correct lines, folds and volume loss. They sit in different product categories and are not interchangeable.
Which treatment areas is Belotero Revive used for?
It is indicated for early-onset photodamaged facial skin in the cheeks, characterised by dehydration, loss of elasticity and firmness, and the presence of superficial fine lines, and is placed in the mid- to deep dermis. Area selection and treatment intervals are the treating practitioner's decisions.
How often can Belotero Revive treatment be repeated?
Belotero Revive can be injected in the cheeks in a single session of up to 3 mL, or in three sessions of up to 2 mL each spaced at least 4 weeks apart. The regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 12 mL. The regimen for an individual patient is set by the treating practitioner.
Customer Reviews
その他の製品: Merz
RADIESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
RADIESSE Products
View all 2Clinic alternatives
Pick up where you left off
Belotero Revive by Merz Aesthetics is the skin quality and skin booster injectable of the BELOTERO range, an injectable resorbable implant developed to revitalise facial skin by rehydrating dry and very dry skin, improving elasticity and firmness and smoothing superficial fine lines. Its indication is early-onset photodamaged facial skin of the cheeks showing dehydration, lost elasticity and firmness, and superficial fine lines, and is placed in the mid- to deep dermis by authorised healthcare professionals. Each 1 mL syringe contains cross-linked sodium hyaluronate 20 mg/ml, produced by fermentation of Streptococcus equi, and glycerol 17.5 mg/ml in phosphate buffer at pH 7, and this presentation contains no lidocaine. The treatment regimen may be renewed at the earliest after 6 months, with a maximum annual dose of 12 mL.
主なメリット: Belotero Revive
- Injectable resorbable implant for early-onset photodamaged facial skin in the cheeks, characterised by dehydration, loss of elasticity and firmness, and superficial fine lines
- Cross-linked sodium hyaluronate 20 mg/ml with glycerol 17.5 mg/ml, in phosphate buffer at pH 7
- Glycerol as a second component is the formulation difference that separates Revive from the fillers in the range
- Contains no lidocaine, so the amide-anaesthetic contraindication that applies to the other grades does not apply here
- Rehydrates dry and very dry skin, improves elasticity and firmness, and smooths superficial fine lines rather than building facial volume
- Placed in the mid- to deep dermis by authorised healthcare professionals
- The treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 12 mL
- Hyaluronate produced by fermentation of Streptococcus equi rather than from an animal source
適応と専門的な使用
主な適応
- Revitalisation of early-onset photodamaged facial skin in the cheeks, characterised by dehydration, loss of elasticity and firmness, and the presence of superficial fine lines
- Rehydration of dry and very dry skin
- Improvement of skin elasticity and firmness
- Smoothening of superficial fine lines by reducing skin roughness
専門的な使用
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
施術部位
- Cheeks
- Skin hydration
- Skin elasticity and firmness
- Superficial fine lines and skin roughness
対象となる患者
Suitable for adult patients assessed as appropriate by the treating practitioner. BELOTERO Revive is contra-indicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, glycerol or BDDE; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, or into skin areas presenting active cutaneous inflammation or infection. This presentation contains no lidocaine, so the amide-anaesthetic contraindication that applies to the lidocaine-containing grades in the range does not apply here. Patient selection and suitability are determined by the practitioner at consultation.
作用の仕組み: Belotero Revive
Belotero Revive works through two components rather than one. Cross-linked sodium hyaluronate at 20 mg/ml provides the hydrating, revitalising base, and glycerol at 17.5 mg/ml is the second component, which is the formulation difference that separates Revive from the BELOTERO fillers. It acts as an injectable resorbable implant that rehydrates dry and very dry skin, improves elasticity and firmness and smooths superficial fine lines, rather than building facial volume. It is placed in the mid- to deep dermis, and the treatment regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 12 mL. Because the target is skin quality rather than facial structure, it is directed at early-onset photodamage in the cheeks characterised by dehydration, loss of elasticity and firmness, and superficial fine lines. This presentation contains no lidocaine.
Allparaで注文する理由
Allparaは、正規品で検証済みの BELOTERO 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。
よくある質問
What does Belotero Revive do?
Belotero Revive is an injectable resorbable implant that revitalises early-onset photodamaged facial skin in the cheeks through rehydration of dry and very dry skin, improvement of elasticity and firmness, and smoothening of superficial fine lines. It works on skin quality rather than correcting folds or restoring volume, and is applied by an authorised healthcare professional.
How does Belotero Revive differ from a BELOTERO dermal filler?
Belotero Revive contains cross-linked sodium hyaluronate 20 mg/ml together with glycerol 17.5 mg/ml, and contains no lidocaine. The glycerol is the formulation difference that separates it from the fillers in the range, which correct lines, folds and volume loss. They sit in different product categories and are not interchangeable.
Which treatment areas is Belotero Revive used for?
It is indicated for early-onset photodamaged facial skin in the cheeks, characterised by dehydration, loss of elasticity and firmness, and the presence of superficial fine lines, and is placed in the mid- to deep dermis. Area selection and treatment intervals are the treating practitioner's decisions.
How often can Belotero Revive treatment be repeated?
Belotero Revive can be injected in the cheeks in a single session of up to 3 mL, or in three sessions of up to 2 mL each spaced at least 4 weeks apart. The regimen may be renewed at the earliest after 6 months, giving a maximum annual dose of 12 mL. The regimen for an individual patient is set by the treating practitioner.